15
May

Oriflame study uses NativeSkin® human skin explant model

NativeSkin®, a novel skin explant model for skin delivery assessment The Genoskin team is proud to announce that Oriflame Cosmetics published an article in the March 2015 edition of Cosmetics & Toiletries under the title “A Novel Skin Explant Model For Skin Delivery Assessment”. The work presented in this article was conducted by Oriflame’s cosmetics experts in their facility in Stockholm. Genoskin has

Read more

15
May

Genoskin obtains 2014 Young Entrepreneur Award

The Great Economy Awards of 2014 More than 400 people attended the Casino Theatre Barriere in Toulouse for the 6th edition of the Great Economy Award (Grands Prix de l’Economie 2014) on December 8th, 2014. The ceremony was organized by Objectif News in partnership with the French Magazine, La Tribune. During the award ceremony, nine companies and managers were put in the spotlight because of their

Read more

15
May

Genoskin joins 3R In Vitro Testing Platform IVTIP

Genoskin joins 3R In Vitro Testing Platform Genoskin is proud to join the In Vitro Testing Industrial Platform. The IVTIP Platform was founded in 1993 and currently comprises 46 companies from different sectors (assay developers, technology providers, chemical, pharmaceutical and cosmetics companies). All members have significant in vitro testing activities. Most of the IVTIP member companies are from Europe, but IVTIP also has members in

Read more

9
Sep

Genoskin attends 2014 meeting European Society for Dermatological Research

44th annual ESDR meeting, Copenhagen, Denmark     Genoskin will attend the 44th annual European Society for Dermatological Research meeting in Copenhagen, Denmark. The congress will take place from September 10 to September 13, 2014. The European Society for Dermatological Research (ESDR) aims to disseminate knowledge and facilitate exchange of information relevant to investigative dermatology between clinicians and scientists worldwide.
Read more
28
Aug

Genoskin attended the 9th World Congress on Alternatives and Animal use in Life Sciences

Genoskin attended the 9th World Congress On Alternatives and Animal Use in The Life Sciences  (WC9 2014) organized in Prague, Czech Republic, from the 24 to the 28 August. “The world congress provides an exceptional forum to underline the importance of both the ethical issues of animal experimentation and the approach to the life sciences in the 21st century.”

27
Aug

Testing steroid-induced changes related to skin atrophy

We are very pleased to announce that our first publication presenting, in particular, the use of our ex vivo human skin model NativeSkin® came out in July in Archives of Dermatological Research.